These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 19351276)

  • 1. Prevention of glucocorticoid-induced osteoporosis.
    van Brussel MS; Bultink IE; Lems WF
    Expert Opin Pharmacother; 2009 Apr; 10(6):997-1005. PubMed ID: 19351276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient satisfaction and efficacy of switching from weekly bisphosphonates to monthly minodronate for treatment and prevention of glucocorticoid-induced osteoporosis in Japanese patients with systemic rheumatic diseases: a randomized, clinical trial.
    Tamechika SY; Sasaki K; Hayami Y; Ohmura SI; Maeda S; Iwagaitsu S; Naniwa T
    Arch Osteoporos; 2018 Jun; 13(1):67. PubMed ID: 29904824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucocorticoid-induced osteoporosis: a review on pathophysiology and treatment options.
    De Nijs RN
    Minerva Med; 2008 Feb; 99(1):23-43. PubMed ID: 18299694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Secondary osteoporosis or secondary contributors to bone loss in fracture. Therapeutic strategy for glucocorticoid-induced osteoporosis].
    Hayakawa N; Suzuki A
    Clin Calcium; 2013 Sep; 23(9):1337-44. PubMed ID: 23999371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Teriparatide or alendronate in glucocorticoid-induced osteoporosis.
    Saag KG; Shane E; Boonen S; Marín F; Donley DW; Taylor KA; Dalsky GP; Marcus R
    N Engl J Med; 2007 Nov; 357(20):2028-39. PubMed ID: 18003959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bisphosphonates and glucocorticoid-induced osteoporosis: cons.
    Lems WF; Saag K
    Endocrine; 2015 Aug; 49(3):628-34. PubMed ID: 26041376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucocorticoid-induced osteoporosis.
    Compston J
    Horm Res; 2003; 60 Suppl 3():77-9. PubMed ID: 14671402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in treatment of glucocorticoid-induced osteoporosis.
    Hsu E; Nanes M
    Curr Opin Endocrinol Diabetes Obes; 2017 Dec; 24(6):411-417. PubMed ID: 28857847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Update on Glucocorticoid Induced Osteoporosis.
    Cho SK; Sung YK
    Endocrinol Metab (Seoul); 2021 Jun; 36(3):536-543. PubMed ID: 34107602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Secondary osteoporosis: underlying disease and the risk for glucocorticoid-induced osteoporosis.
    Boling EP
    Clin Ther; 2004 Jan; 26(1):1-14. PubMed ID: 14996513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Glucocorticoid and Bone. Efficacy and safety of bisphosphonate in treatment of glucocorticoid induced osteoporosis].
    Tanaka I
    Clin Calcium; 2014 Sep; 24(9):1371-8. PubMed ID: 25177010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucocorticoid-induced osteoporosis.
    Berris KK; Repp AL; Kleerekoper M
    Curr Opin Endocrinol Diabetes Obes; 2007 Dec; 14(6):446-50. PubMed ID: 17982350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucocorticoid induced osteoporosis.
    Hu K; Adachi JD
    Expert Rev Endocrinol Metab; 2019 Jul; 14(4):259-266. PubMed ID: 31094232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anabolic therapy in glucocorticoid-induced osteoporosis.
    Sambrook PN
    N Engl J Med; 2007 Nov; 357(20):2084-6. PubMed ID: 18003966
    [No Abstract]   [Full Text] [Related]  

  • 15. [Glucocorticoid induced osteoporosis].
    Anić B; Mayer M
    Reumatizam; 2014; 61(2):105-12. PubMed ID: 25427404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucocorticoid-induced osteoporosis and parathyroid hormone.
    Carpinteri R; Porcelli T; Mejia C; Patelli I; Bilezikian JP; Canalis E; Angeli A; Giustina A; Mazziotti G
    J Endocrinol Invest; 2010; 33(7 Suppl):16-21. PubMed ID: 20938221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucocorticoid-induced osteoporosis: clinical and therapeutic aspects.
    Mazziotti G; Giustina A; Canalis E; Bilezikian JP
    Arq Bras Endocrinol Metabol; 2007 Nov; 51(8):1404-12. PubMed ID: 18209880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical question: What is the best approach to managing glucocorticoid-induced osteoporosis?
    Compston J
    Clin Endocrinol (Oxf); 2011 May; 74(5):547-50. PubMed ID: 21470278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An update on glucocorticoid-induced osteoporosis.
    Woolf AD
    Curr Opin Rheumatol; 2007 Jul; 19(4):370-5. PubMed ID: 17551369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of osteoporosis pharmacotherapies in preventing fracture among oral glucocorticoid users: a network meta-analysis.
    Amiche MA; Albaum JM; Tadrous M; Pechlivanoglou P; Lévesque LE; Adachi JD; Cadarette SM
    Osteoporos Int; 2016 Jun; 27(6):1989-98. PubMed ID: 26782683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.